Diabetes

"milgamma® Mono 150. Active ingredient: Benfotiamine 150 mg. Areas of application: Therapy or prophylaxis of clinical vitamin B1 deficiency states, provided that they cannot be remedied; Treatment of neuropathies and cardiovascula. Sturgeon., D. can be caused by vitamin B1 deficiency. Read the package supplement and ask your doctor or pharmacist for risks and side effects."

"milgamma® Mono 50 Active ingredient: Benfotiamine 50 mg. Areas of application: Therapy or prophylaxis of clinical vitamin B1 deficiency states, provided that they cannot be remedied; Treatment of neuropathies and cardiovascula. Sturgeon., D. can be caused by vitamin B1 deficiency. Read the package supplement and ask your doctor or pharmacist for risks and side effects."